Baudax Bio Inc reports results for the quarter ended in March - Earnings Summary

Baudax Bio

05/05/2022 14:31

* Baudax Bio Inc  BXRX.OQ  reported a quarterly adjusted
loss of
$3.17​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of $1.85 per
share.
    * Revenue rose 113.1% to $422.00 thousand from a year ago; 
analysts expected $557.00 thousand. 
    * Baudax Bio Inc's reported EPS for the quarter was a loss
of
$3.17​.
    * The mean earnings estimate of analysts had risen by
about 60.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Baudax Bio Inc shares had fallen by 1.7% this quarter and
lost 77.3% so far this year.
    * The company reported a quarterly loss of $12.81 million.
    * Wall Street's median 12-month price target for Baudax Bio
Inc is
$10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 01:31 p.m.  ​All
figures in US dollars unless otherwise stated